Innovative Ways of Patient Involvement in Medicines Development

PharmaTalkRadio

English - June 20, 2017 15:00 - 54 minutes - 49.4 MB - ★★★★ - 16 ratings
Science pharmaceutical biotech clinical trials patient engagement immuno-oncology drug delivery r&d Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Sequencing of Combination Agents in Immuno-Oncology with Dr Charles Drake

Next Episode: Increasingly Critical Role of Predictive Biomarkers in Cancer Immunotherapy

Originally recorded at the inaugural Patients as Partners Europe event, held in London in February 2017. Patient, industry, and regulatory perspectives are provided by Alastair Kent of Genetic Alliance UK, Dr Anton Hoos of Amgen Europe, and Isabelle Moulon of the EMD as they discuss on innovative ways of to include patient involvement in medicines development.

The Patients as Partners Europe program seeks to understand and incorporate the patient's voice in designing clinical trials and developing a clinical endpoint, as well as vastly improve the patient's entire experience in a clinical trial. The 2nd annual Patients as Partners EU event will be held January 23-24, 2018 at Radisson Blu Portman Hotel, London, UK.